Pain drug behind French trial that went wrong


A class of drug that has been trialled in osteoarthritis has been implicated in the clinical trial last week that went tragically wrong, leaving one volunteer dead and four with neurological symptoms of varying severity. The Portuguese pharmaceutical company that sponsored the trial, Bial, has confirmed that the drug involved in the phase I study was ...


Already a member? Login to keep reading


OR
© 2017 the limbic